MedGrad E-CLIP: Enhancing Trust and Transparency in AI-Driven Skin Lesion Diagnosis

As deep learning models gain attraction in medical data, ensuring transparent and trustworthy decision-making is essential. In skin cancer diagnosis, while advancements in lesion detection and classification have improved accuracy, the black-box nature of these methods poses challenges in understanding their decision processes, leading to trust issues among physicians. This study leverages the CLIP (Contrastive Language-Image Pretraining) model, trained on different skin lesion datasets, to capture meaningful relationships between visual features and diagnostic criteria terms. To further enhance transparency, we propose a method called MedGrad E-CLIP, which builds on gradient-based E-CLIP by incorporating a weighted entropy mechanism designed for complex medical imaging like skin lesions. This approach highlights critical image regions linked to specific diagnostic descriptions. The developed integrated pipeline not only classifies skin lesions by matching corresponding descriptions but also adds an essential layer of explainability developed especially for medical data. By visually explaining how different features in an image relates to diagnostic criteria, this approach demonstrates the potential of advanced vision-language models in medical image analysis, ultimately improving transparency, robustness, and trust in AI-driven diagnostic systems.

Marker Track: Accurate Fiducial Marker Tracking for Evaluation of Residual Motions During Breath-Hold Radiotherapy

Fiducial marker positions in projection image of cone-beam computed tomography (CBCT) scans have been studied to evaluate daily residual motion during breath-hold radiation therapy. Fiducial marker migration posed challenges in accurately locating markers, prompting the development of a novel algorithm that reconstructs volumetric probability maps of marker locations from filtered gradient maps of projections. This guides the development of a Python-based algorithm to detect fiducial markers in projection images using Meta AI's Segment Anything Model 2 (SAM 2). Retrospective data from a pancreatic cancer patient with two fiducial markers were analyzed. The three-dimensional (3D) marker positions from simulation computed tomography (CT) were compared to those reconstructed from CBCT images, revealing a decrease in relative distances between markers over time. Fiducial markers were successfully detected in 2777 out of 2786 projection frames. The average standard deviation of superior-inferior (SI) marker positions was 0.56 mm per breath-hold, with differences in average SI positions between two breath-holds in the same scan reaching up to 5.2 mm, and a gap of up to 7.3 mm between the end of the first and beginning of the second breath-hold. 3D marker positions were calculated using projection positions and confirmed marker migration. This method effectively calculates marker probability volume and enables accurate fiducial marker tracking during treatment without requiring any specialized equipment, additional radiation doses, or manual initialization and labeling. It has significant potential for automatically assessing daily residual motion to adjust planning margins, functioning as an adaptive radiation therapy tool.

From Images to Insights: Transforming Brain Cancer Diagnosis with Explainable AI

Brain cancer represents a major challenge in medical diagnostics, requisite precise and timely detection for effective treatment. Diagnosis initially relies on the proficiency of radiologists, which can cause difficulties and threats when the expertise is sparse. Despite the use of imaging resources, brain cancer remains often difficult, time-consuming, and vulnerable to intraclass variability. This study conveys the Bangladesh Brain Cancer MRI Dataset, containing 6,056 MRI images organized into three categories: Brain Tumor, Brain Glioma, and Brain Menin. The dataset was collected from several hospitals in Bangladesh, providing a diverse and realistic sample for research. We implemented advanced deep learning models, and DenseNet169 achieved exceptional results, with accuracy, precision, recall, and F1-Score all reaching 0.9983. In addition, Explainable AI (XAI) methods including GradCAM, GradCAM++, ScoreCAM, and LayerCAM were employed to provide visual representations of the decision-making processes of the models. In the context of brain cancer, these techniques highlight DenseNet169's potential to enhance diagnostic accuracy while simultaneously offering transparency, facilitating early diagnosis and better patient outcomes.

Multivariate Feature Selection and Autoencoder Embeddings of Ovarian Cancer Clinical and Genetic Data

This study explores a data-driven approach to discovering novel clinical and genetic markers in ovarian cancer (OC). Two main analyses were performed: (1) a nonlinear examination of an OC dataset using autoencoders, which compress data into a 3-dimensional latent space to detect potential intrinsic separability between platinum-sensitive and platinum-resistant groups; and (2) an adaptation of the informative variable identifier (IVI) to determine which features (clinical or genetic) are most relevant to disease progression. In the autoencoder analysis, a clearer pattern emerged when using clinical features and the combination of clinical and genetic data, indicating that disease progression groups can be distinguished more effectively after supervised fine tuning. For genetic data alone, this separability was less apparent but became more pronounced with a supervised approach. Using the IVI-based feature selection, key clinical variables (such as type of surgery and neoadjuvant chemotherapy) and certain gene mutations showed strong relevance, along with low-risk genetic factors. These findings highlight the strength of combining machine learning tools (autoencoders) with feature selection methods (IVI) to gain insights into ovarian cancer progression. They also underscore the potential for identifying new biomarkers that integrate clinical and genomic indicators, ultimately contributing to improved patient stratification and personalized treatment strategies.

SAM-Mamba: Mamba Guided SAM Architecture for Generalized Zero-Shot Polyp Segmentation

Polyp segmentation in colonoscopy is crucial for detecting colorectal cancer. However, it is challenging due to variations in the structure, color, and size of polyps, as well as the lack of clear boundaries with surrounding tissues. Traditional segmentation models based on Convolutional Neural Networks (CNNs) struggle to capture detailed patterns and global context, limiting their performance. Vision Transformer (ViT)-based models address some of these issues but have difficulties in capturing local context and lack strong zero-shot generalization. To this end, we propose the Mamba-guided Segment Anything Model (SAM-Mamba) for efficient polyp segmentation. Our approach introduces a Mamba-Prior module in the encoder to bridge the gap between the general pre-trained representation of SAM and polyp-relevant trivial clues. It injects salient cues of polyp images into the SAM image encoder as a domain prior while capturing global dependencies at various scales, leading to more accurate segmentation results. Extensive experiments on five benchmark datasets show that SAM-Mamba outperforms traditional CNN, ViT, and Adapter-based models in both quantitative and qualitative measures. Additionally, SAM-Mamba demonstrates excellent adaptability to unseen datasets, making it highly suitable for real-time clinical use.

MRANet: A Modified Residual Attention Networks for Lung and Colon Cancer Classification

Lung and colon cancers are predominant contributors to cancer mortality. Early and accurate diagnosis is crucial for effective treatment. By utilizing imaging technology in different image detection, learning models have shown promise in automating cancer classification from histopathological images. This includes the histopathological diagnosis, an important factor in cancer type identification. This research focuses on creating a high-efficiency deep-learning model for identifying lung and colon cancer from histopathological images. We proposed a novel approach based on a modified residual attention network architecture. The model was trained on a dataset of 25,000 high-resolution histopathological images across several classes. Our proposed model achieved an exceptional accuracy of 99.30%, 96.63%, and 97.56% for two, three, and five classes, respectively; those are outperforming other state-of-the-art architectures. This study presents a highly accurate deep learning model for lung and colon cancer classification. The superior performance of our proposed model addresses a critical need in medical AI applications.

Augmented Intelligence for Multimodal Virtual Biopsy in Breast Cancer Using Generative Artificial Intelligence

Full-Field Digital Mammography (FFDM) is the primary imaging modality for routine breast cancer screening; however, its effectiveness is limited in patients with dense breast tissue or fibrocystic conditions. Contrast-Enhanced Spectral Mammography (CESM), a second-level imaging technique, offers enhanced accuracy in tumor detection. Nonetheless, its application is restricted due to higher radiation exposure, the use of contrast agents, and limited accessibility. As a result, CESM is typically reserved for select cases, leaving many patients to rely solely on FFDM despite the superior diagnostic performance of CESM. While biopsy remains the gold standard for definitive diagnosis, it is an invasive procedure that can cause discomfort for patients. We introduce a multimodal, multi-view deep learning approach for virtual biopsy, integrating FFDM and CESM modalities in craniocaudal and mediolateral oblique views to classify lesions as malignant or benign. To address the challenge of missing CESM data, we leverage generative artificial intelligence to impute CESM images from FFDM scans. Experimental results demonstrate that incorporating the CESM modality is crucial to enhance the performance of virtual biopsy. When real CESM data is missing, synthetic CESM images proved effective, outperforming the use of FFDM alone, particularly in multimodal configurations that combine FFDM and CESM modalities. The proposed approach has the potential to improve diagnostic workflows, providing clinicians with augmented intelligence tools to improve diagnostic accuracy and patient care. Additionally, as a contribution to the research community, we publicly release the dataset used in our experiments, facilitating further advancements in this field.

A new Time-decay Radiomics Integrated Network (TRINet) for short-term breast cancer risk prediction

To facilitate early detection of breast cancer, there is a need to develop short-term risk prediction schemes that can prescribe personalized/individualized screening mammography regimens for women. In this study, we propose a new deep learning architecture called TRINet that implements time-decay attention to focus on recent mammographic screenings, as current models do not account for the relevance of newer images. We integrate radiomic features with an Attention-based Multiple Instance Learning (AMIL) framework to weigh and combine multiple views for better risk estimation. In addition, we introduce a continual learning approach with a new label assignment strategy based on bilateral asymmetry to make the model more adaptable to asymmetrical cancer indicators. Finally, we add a time-embedded additive hazard layer to perform dynamic, multi-year risk forecasting based on individualized screening intervals. We used two public datasets, namely 8,528 patients from the American EMBED dataset and 8,723 patients from the Swedish CSAW dataset in our experiments. Evaluation results on the EMBED test set show that our approach significantly outperforms state-of-the-art models, achieving AUC scores of 0.851, 0.811, 0.796, 0.793, and 0.789 across 1-, 2-, to 5-year intervals, respectively. Our results underscore the importance of integrating temporal attention, radiomic features, time embeddings, bilateral asymmetry, and continual learning strategies, providing a more adaptive and precise tool for short-term breast cancer risk prediction.

Improved joint modelling of breast cancer radiomics features and hazard by image registration aided longitudinal CT data

Patients with metastatic breast cancer (mBC) undergo continuous medical imaging during treatment, making accurate lesion detection and monitoring over time critical for clinical decisions. Predicting drug response from post-treatment data is essential for personalized care and pharmacological research. In collaboration with the U.S. Food and Drug Administration and Novartis Pharmaceuticals, we analyzed serial chest CT scans from two large-scale Phase III trials, MONALEESA 3 and MONALEESA 7. This paper has two objectives (a) Data Structuring developing a Registration Aided Automated Correspondence (RAMAC) algorithm for precise lesion tracking in longitudinal CT data, and (b) Survival Analysis creating imaging features and models from RAMAC structured data to predict patient outcomes. The RAMAC algorithm uses a two phase pipeline: three dimensional rigid registration aligns CT images, and a distance metric-based Hungarian algorithm tracks lesion correspondence. Using structured data, we developed interpretable models to assess progression-free survival (PFS) in mBC patients by combining baseline radiomics, post-treatment changes (Weeks 8, 16, 24), and demographic features. Radiomics effects were studied across time points separately and through a non-correlated additive framework. Radiomics features were reduced using (a) a regularized (L1-penalized) additive Cox proportional hazards model, and (b) variable selection via best subset selection. Performance, measured using the concordance index (C-index), improved with additional time points. Joint modeling, considering correlations among radiomics effects over time, provided insights into relationships between longitudinal radiomics and survival outcomes.

Influence of High-Performance Image-to-Image Translation Networks on Clinical Visual Assessment and Outcome Prediction: Utilizing Ultrasound to MRI Translation in Prostate Cancer

Purpose: This study examines the core traits of image-to-image translation (I2I) networks, focusing on their effectiveness and adaptability in everyday clinical settings. Methods: We have analyzed data from 794 patients diagnosed with prostate cancer (PCa), using ten prominent 2D/3D I2I networks to convert ultrasound (US) images into MRI scans. We also introduced a new analysis of Radiomic features (RF) via the Spearman correlation coefficient to explore whether networks with high performance (SSIM>85%) could detect subtle RFs. Our study further examined synthetic images by 7 invited physicians. As a final evaluation study, we have investigated the improvement that are achieved using the synthetic MRI data on two traditional machine learning and one deep learning method. Results: In quantitative assessment, 2D-Pix2Pix network substantially outperformed the other 7 networks, with an average SSIM~0.855. The RF analysis revealed that 76 out of 186 RFs were identified using the 2D-Pix2Pix algorithm alone, although half of the RFs were lost during the translation process. A detailed qualitative review by 7 medical doctors noted a deficiency in low-level feature recognition in I2I tasks. Furthermore, the study found that synthesized image-based classification outperformed US image-based classification with an average accuracy and AUC~0.93. Conclusion: This study showed that while 2D-Pix2Pix outperformed cutting-edge networks in low-level feature discovery and overall error and similarity metrics, it still requires improvement in low-level feature performance, as highlighted by Group 3. Further, the study found using synthetic image-based classification outperformed original US image-based methods.